4.2 Review

Fecal Microbiota Transplantation as Therapy for Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis

Related references

Note: Only part of the references are listed.
Review Gastroenterology & Hepatology

Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020

Cicilia Marcella et al.

Summary: The study evaluated the safety of FMT by summarising reported Adverse Events over a 20-year period, finding that most FMT-related AEs were mild or moderate and self-limiting. Serious adverse events mainly occurred in patients with mucosal barrier injury, indicating the importance of improving FMT methodology to reduce such risks.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Review Gastroenterology & Hepatology

Clinical remission of ulcerative colitis after different modes of faecal microbiota transplantation: a meta-analysis

Li-li Tang et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2020)

Article Gastroenterology & Hepatology

Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes

Qianqian Li et al.

Clinical and Translational Gastroenterology (2020)

Article Public, Environmental & Occupational Health

Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis

Xiao Ding et al.

DRUG SAFETY (2019)

Article Pharmacology & Pharmacy

Evolution of fecal microbiota transplantation in methodology and ethical issues

Faming Zhang et al.

CURRENT OPINION IN PHARMACOLOGY (2019)

Article Medicine, General & Internal

Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial

Samuel P. Costello et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Review Gastroenterology & Hepatology

Systematic Review and Meta-analysis: Fecal Microbiota Transplantation for Treatment of Active Ulcerative Colitis

Neeraj Narula et al.

INFLAMMATORY BOWEL DISEASES (2017)

Article Medicine, General & Internal

Fecal Microbiota Transplantation

Arjun Gupta et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Review Medicine, General & Internal

Ulcerative colitis

Ryan Ungaro et al.

LANCET (2017)

Article Gastroenterology & Hepatology

Donor Species Richness Determines Faecal Microbiota Transplantation Success in Inflammatory Bowel Disease

Severine Vermeire et al.

JOURNAL OF CROHNS & COLITIS (2016)

Article Gastroenterology & Hepatology

Colonic transendoscopic enteral tubing: A novel way of transplanting fecal microbiota

Zhaoyuan Peng et al.

ENDOSCOPY INTERNATIONAL OPEN (2016)

Article Gastroenterology & Hepatology

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

Noortje G. Rossen et al.

GASTROENTEROLOGY (2015)

Article Gastroenterology & Hepatology

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

Colleen R. Kelly et al.

GASTROENTEROLOGY (2015)

Meeting Abstract Gastroenterology & Hepatology

Long side-to-side isoperistaltic strictureplasty over the ileocecal valve: a prospective analysis of feasibility and medium term outcome

A. de Buck van Overstraeten et al.

JOURNAL OF CROHNS & COLITIS (2015)

Article Medicine, General & Internal

Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile

Els van Nood et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Medicine, General & Internal

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Mathematical & Computational Biology

Quantifying heterogeneity in a meta-analysis

JPT Higgins et al.

STATISTICS IN MEDICINE (2002)